ARD Lay summaries

Showing results 1 - 10 of 100

Sorted by most recent

TitleAuthorDate

Associations of residential greenness with bone mineral density and osteoporosis: the modifying effect of genetic susceptibility

Tingting Tan, Linxi Tang, Xiaoning Guo, Tao Li, Yaohua Tian, Zhengxiao Ouyang

5 March 2024

Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial

Fabian Proft, Murat Torgutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen JackiSee the full list of authors

16 January 2024

Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial

Max M H Teuwen, Salima F E van Weely, Thea P M Vliet Vlieland, Maria A T van Wissen, Wilfred F Peter, Alfons A den Broeder, Dirkjan van Schaardenburg, Wilbert B van den Hout, Cornelia H M Van den Ende, Maaike G J Gademan

3 January 2024

Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients

Gudrun David Sigmo, Solveig Hauge, Karl Ove Hufthammer, Marianne Wallenius, Kjell Åsmund Salvesen, Anne Kjersti Nesje Daltveit, Gunnstein Bakland, Bjorg-Tilde Svanes Fevang

23 January 2024

Correction: Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance

BMJ Publishing Group Ltd and European League Against Rheumatism

15 February 2024

Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica

Eugenio De Miguel, Rositsa Karalilova, Pierluigi Macchioni, Cristina Ponte, Edoardo Conticini, Sharon Cowley, Alessandro Tomelleri, Sara Monti, Irene Monjo, Zguro Batalov, Giulia Klinowski, Paolo Falsetti, David J Kane, Corrado Campochiaro, Alojzija Hočevar

6 November 2023

Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial

Reza Zonozi, Frank B Cortazar, Anushya Jeyabalan, Gabriel Sauvage, Pravarut Nithagon, Noah R Huizenga, Jillian M Rosenthal, Alexander Sipilief, Katherine Cosgrove, Karen A Laliberte, Eugene P Rhee, William F Pendergraft, III, John L Niles

11 December 2023

Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials

Florence Delestre, Pierre Charles, Alexandre Karras, Christian Pagnoux, Antoine Néel, Pascal Cohen, Olivier Aumaître, Stanislas Faguer, Pierre Gobert, François Maurier, Maxime Samson, Pascal Godmer, Bernard Bonnotte, Vincent Cottin, Catherine Hanrotel-SaliouSee the full list of authors

2 November 2023

Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres

Matthias Dreher, Torsten Witte, Kirsten Hoeper, Gunter Assmann, Fabian Proft, Denis Poddubnyy, Niels Murawski, Konstantinos Triantafyllias, Marlon Grodd, Erika Graf, Urs A Fichtner, Harald Binder, Jan Zeidler, Juliana Rachel Hoeper, Johanna CallhoffSee the full list of authors

27 October 2023

Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study

Shunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-ichiro KagamiSee the full list of authors

21 September 2023

12 3 4 5 6 7 8 9 10 Next